These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2630636)

  • 1. [Dissolution properties and bioavailability of ground mixture of N,N-dimethylcarbamoylmethyl alpha, 2-dimethyl-5H-[1]benzopyrano[2,3-b]-pyridine-7-acetate with various pharmaceutical ingredients].
    Yamada I; Kawata M; Shibata T; Ogawa K; Yokobe T
    Yakugaku Zasshi; 1989 Dec; 109(12):932-7. PubMed ID: 2630636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of gastric acidity on bioavailability of N,N-dimethylcarbamoylmethylalpha, 2-dimethyl-5H-[1]benzopyrano[2,3-b]pyridine-7-acetate, a new prodrug-type anti-inflammatory agent.
    Yamada I; Goda T; Kawata M; Mizuta H; Ogawa K; Yokobe T
    Chem Pharm Bull (Tokyo); 1989 Dec; 37(12):3372-5. PubMed ID: 2632086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic behaviour in polymorphonuclear leucocytes of N,N-dimethylcarbamoylmethyl alpha,2-dimethyl-5H-[1]benzopyrano[2,3-b]- pyridine-7-acetate (Y-23023), a new prodrug type of anti-inflammatory agent, and indomethacin after oral administrations in rats.
    Yamada I; Nagamatsu Y; Imayoshi T; Shibata M; Tsuji A
    J Pharm Pharmacol; 1994 Jul; 46(7):614-6. PubMed ID: 7996395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal physiology-regulated dogs for bioavailability evaluation of an oral controlled-release dosage form composed of pulsatile release granules.
    Sagara K; Yamada I; Matsuura Y; Kawata M; Shibata M
    Biol Pharm Bull; 1996 Sep; 19(9):1184-8. PubMed ID: 8889038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of low-substituted hydroxypropylcellulose in dissolution and bioavailability of novel fine granule system for masking bitter taste.
    Shirai Y; Sogo K; Fujioka H; Nakamura Y
    Biol Pharm Bull; 1994 Mar; 17(3):427-31. PubMed ID: 7811321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synthesis, pharmacological activity and biopharmaceutical characteristics of alpha,2-dimethyl-5H-[1]benzopyrano[2,3-b]pyridine-7-acetates].
    Kawasaki K; Yamada I; Oe T; Tsuruda M; Terasawa M; Imayoshi T; Yasunaga Y; Goto K
    Yakugaku Zasshi; 1989 Nov; 109(11):827-34. PubMed ID: 2614665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of dissolution rate and oral bioavailability of a sparingly water-soluble drug, (+/-)-5-[[2-(2-naphthalenylmethyl)-5-benzoxazolyl]-methyl]- 2, 4-thiazolidinedione, in co-ground mixture with D-mannitol.
    Kubo H; Mizobe M
    Biol Pharm Bull; 1997 Apr; 20(4):460-3. PubMed ID: 9145232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel fine granule system for masking bitter taste.
    Shirai Y; Sogo K; Yamamoto K; Kojima K; Fujioka H; Makita H; Nakamura Y
    Biol Pharm Bull; 1993 Feb; 16(2):172-7. PubMed ID: 8395930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of gastric acidity-controlled beagle dog to bioavailability study of cinnarizine].
    Yamada I; Goda T; Kawata M; Ogawa K
    Yakugaku Zasshi; 1990 Apr; 110(4):280-5. PubMed ID: 2376821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved dissolution and absorption of ketoconazole in the presence of organic acids as pH-modifiers.
    Adachi M; Hinatsu Y; Kusamori K; Katsumi H; Sakane T; Nakatani M; Wada K; Yamamoto A
    Eur J Pharm Sci; 2015 Aug; 76():225-30. PubMed ID: 25988287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hydroxypropylcellulose and Tween 80 on physicochemical properties and bioavailability of ezetimibe-loaded solid dispersion.
    Rashid R; Kim DW; Din FU; Mustapha O; Yousaf AM; Park JH; Kim JO; Yong CS; Choi HG
    Carbohydr Polym; 2015 Oct; 130():26-31. PubMed ID: 26076597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site specific solubility improvement using solid dispersions of HPMC-AS/HPC SSL--mixtures.
    Zecevic DE; Meier R; Daniels R; Wagner KG
    Eur J Pharm Biopharm; 2014 Jul; 87(2):264-70. PubMed ID: 24768770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced dissolution and bioavailability of raloxifene hydrochloride by co-grinding with different superdisintegrants.
    Jagadish B; Yelchuri R; K B; Tangi H; Maroju S; Rao VU
    Chem Pharm Bull (Tokyo); 2010 Mar; 58(3):293-300. PubMed ID: 20190431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissolution behavior and bioavailability of phenytoin from a ground mixture with microcrystalline cellulose.
    Yamamoto K; Nakano M; Arita T; Takayama Y; Nakai Y
    J Pharm Sci; 1976 Oct; 65(10):1484-8. PubMed ID: 978407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Manufacturing Methods on Dissolution and Absorption of Ketoconazole in the Presence of Organic Acid as a pH Modifier.
    Adachi M; Hinatsu Y; Kusamori K; Katsumi H; Sakane T; Nakatani M; Wada K; Yamamoto A
    AAPS PharmSciTech; 2017 May; 18(4):1203-1212. PubMed ID: 27431914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
    Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
    Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an abiraterone acetate formulation with improved oral bioavailability guided by absorption modeling based on in vitro dissolution and permeability measurements.
    Solymosi T; Ötvös Z; Angi R; Ordasi B; Jordán T; Semsey S; Molnár L; Ránky S; Filipcsei G; Heltovics G; Glavinas H
    Int J Pharm; 2017 Oct; 532(1):427-434. PubMed ID: 28919099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs - a case study with valsartan.
    Chella N; Tadikonda R
    Drug Dev Ind Pharm; 2015 Jun; 41(6):888-97. PubMed ID: 24796274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Powder coating mixture of a novel anxiolytic, Y-23684: dissolution characteristics and bioavailability.
    Samemoto H; Yamada I; Yata T; Ogawa K
    Chem Pharm Bull (Tokyo); 1992 Apr; 40(4):1007-10. PubMed ID: 1356081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucosamine HCl as a new carrier for improved dissolution behaviour: effect of grinding.
    Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
    Colloids Surf B Biointerfaces; 2010 Nov; 81(1):96-109. PubMed ID: 20674291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.